Related Experiment Video
Updated: Dec 23, 2025

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
[CME: Familial Hypercholesterolemia - Statin Treatment during Pregnancy and Breastfeeding]
Pranvera Shala-Haskaj1, Franziska Krähenmann2, Dörthe Schmidt1
1Klinik und Poliklinik für Innere Medizin, Universitätsspital Zürich.
Insights
Familial hypercholesterolemia requires early statin treatment due to high cardiovascular risk. However, statin use during pregnancy and breastfeeding is limited, necessitating careful management and consultation with healthcare providers.
Area of Science:
- Cardiology
- Pharmacology
- Genetics
Background:
- Familial hypercholesterolemia (FH) presents a lifelong elevated cardiovascular risk.
- Intensive statin therapy is crucial for managing FH.
- Current guidelines on statin use during pregnancy and breastfeeding are limited and require clarification.
Purpose of the Study:
- To review the current understanding and guidelines regarding statin treatment for familial hypercholesterolemia during pregnancy and breastfeeding.
- To highlight the risks associated with statin use in pregnant and lactating women with FH.
- To provide recommendations for managing FH in women of childbearing potential.
Main Methods:
- Literature review of existing guidelines and studies on statin use in pregnancy.
- Analysis of recommendations from bodies like NICE regarding conception, contraception, and lactation.
- Summary of clinical considerations for unplanned pregnancies in FH patients.
Main Results:
- NICE guidelines recommend discontinuing statins three months prior to conception to mitigate teratogenicity.
- Contraception is advised during statin treatment for women with FH.
- Lipid-lowering drugs are generally contraindicated until lactation ceases.
Conclusions:
- Women with familial hypercholesterolemia must carefully manage statin therapy around conception and during pregnancy/breastfeeding.
- Discontinuation of statins and medical consultation are essential in cases of unplanned pregnancy.
- Further research is needed to establish definitive safety profiles for statin use in this population.
Abstract:
CME: Familial Hypercholesterolemia - Statin Treatment during Pregnancy and Breastfeeding Abstract. Patients with familial hypercholesterolemia have a permanent increased cardiovascular risk. Thus, early detection and intensive treatment with statins is vital. However, treatment during pregnancy using statins remains unclear and limited. According to the NICE guidelines, women should stop statins three months before conception in order to avoid teratogenicity. In addition, contraception during statin treatment is recommended. Moreover, women should not take lipid-lowering drugs until the end of lactation. In the event of an unplanned pregnancy, a woman with familial hypercholesterolemia should discontinue the statins and consult her doctor.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis IV: Nursing Management
Lipids: Dietary Sources and Requirements
Angina IV: Management

